Galapagos | DEBITO



Debt Cambiamento Data
AstraZeneca USD 30.3B 1.27B 2024-12
Biogen USD 6.3B 1.9M 2024-12
Genmab DKK 1.03B 42M 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
GRIFOLS EUR 9.23B 626.05M 2024-12
Hikma Pharmaceutical USD 1.28B 85M 2024-06
Incyte USD 37.96M 5.81M 2024-12
Merck EUR 11.38B 636M 2024-09
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 23.75B 5.33B 2024-06
UCB EUR 3.03B 13M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Galapagos DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.